Government and Public Health

A debate is ongoing if Olympic Games should be cancelled, moved or delayed because of the Public Health Emergency of International Concern declared by WHO on 1st February 2016 on microcephaly in Brazil, which is being proven to be associated with Zika infection. On May 25th, 150 experts in bioethics, public health and social sciences signed an open letter to the WHO, asking to skip the Games, in order to avoid a further spread of the epidemic.

June 30, 2016

Albert Osterhaus, director of the Research Center for Emerging Infections and Zoonoses (RIZ) in Hannover, Germany, and Chairman of the European Working group on Influenza (ESW), is one of the top virologist in the world, who has discovered more than 50 new viruses over the last decades. In this short video he explains why the word “pandemic” can be a cause of misunderstanding between health authorities and the public, as it happened in 2009, when the new emerging flu virus A(H1N1) turned out to be milder than expected in the beginning.

Topic: 
Wednesday, November 16, 2016 (All day)

Public engagement that sets citizens and stakeholders as co-designers and collaborators of R&I activities can contribute to more dynamic and responsible governance of research and innovation. Public Engagement for Research, Practice and Policy conference, to be organized on November 16-17 in Brussels, calls for experts, stakeholders, policy-makers, entrepreneurs, researchers, regional authorities and Commission officials to a joint discussion on this theme.

June 13, 2016

One of the main source of distrust towards public health authorities is the suspect of hidden connections with the pharmaceutical industry, but, in case of a severe pandemic, an adequate supply of antivirals and vaccines is essential. ASSET asked Norman Begg, GSK Vice President, Head of Scientific Affairs and Public Health, Vaccines, what kind of agreements exist for Public Health Emergencies of International Concern (PHEIC) or of a pandemic, between big pharma and WHO. The answer for the two situations is not the same.

Tags: 

Until the end, it seemed it could sort out to be a happy-ending story, a demonstration of how new social networks, renown for spreading misinformation, can also correct it, when used properly. But the unfortunately predictable finale showed the opposite: counteracting false ideas about vaccines is not that easy. It will take time, a big deal of patience, communication skills and a good, coordinated strategy as well.

It is never easy to develop definitions, especially when we are talking about something that is emerging and changing as we speak. This is the case for Responsible Research and Innovation (RRI), an emerging process within European Framework Programs whose definition is new and evolving. However, we can certainly identify a number of key characteristics of RRI, which is an umbrella term including a wide variety of notions, coming from the academia and politics.

May 11, 2016

Albert Osterhaus, director of the Research Center for Emerging Infections and Zoonoses (RIZ) in Hannover, Germany, is also a vet and a strong promoter of the One Health movement, which aims to consider animals and humans together, as possible sources and vectors of emerging diseases. In his lab MERS-Cov was discovered, which has caused thousands of cases and hundreds of deaths so far, mainly in the Middle East and in Korea. He has studied a new strategy to counteract this disease, vaccinating the dromedary camels, which are the main source of human infections.

Tags: 

“We are so close to ending the polio” and “Still 15 years to a polio-free world” are not contradictory statements. They instead describe, with different degree of optimism, the current framework and the objective to be pursued in the fight against this disease. In other words, we are closer than ever to the target of a world free of polio, but much remains to be done to carry the world across the threshold. Polio eradication is the next issue public health authorities will be committed to in midterm future.

ECDC internal meeting
April 14 2016.

Pages

Subscribe to Government and Public Health

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence